1. Omnicell ( OMCL) provides automated solutions for hospital medication and supply management. It designs solutions to enable healthcare facilities to acquire, manage, dispense and administer medication and medical-surgical supplies. Besides, it is focused on improving patient safety, reducing medication errors, improving workflow, and operating efficiency. The company will release its second quarter 2011 results on July 22. Analysts polled by Bloomberg expect Omnicell to record second-quarter net income of $4.51 million or 13 cents per share, versus $4.06 million or 12 cents per share in the same quarter prior year. Sales are seen soaring by 9% to $59.87 million from $54.69 million earlier. Gross margin is likely to expand to 54.77% from 52.78%, while EBITDA is estimated to rise to $7.64 million from $5.67 million in the year-ago period. Operating profit is seen rising by 5% during the quarter. Recently, it was known that president and CEO of the company sold 6,936 shares on July 13 at an average price of $17 per share. Of the nine analysts covering the stock, 78% recommend a buy and 11% suggest a hold. Analysts polled by Bloomberg foresee the stock gaining an average 5.5% to $17.50 in the upcoming 12 months. >>To see these stocks in action, visit the 6 Health Care Stocks to Gain on Earnings portfolio on Stockpickr.